Trial site
Naples
- 12running trials
- 14closed trials
The trials here
What the 26 trials at this site are about, from their registry records.
- Conditions
- Lung cancer4 trials
- Melanoma4 trials
- Multiple sclerosis4 trials
- Chronic myeloid leukaemia3 trials
- Coronary artery disease3 trials
- Stroke3 trials
- Myeloproliferative neoplasms2 trials
- Prostate cancer2 trials
- Triple-negative breast cancer2 trials
- Acute myeloid leukaemia1 trial
- Childhood cancers1 trial
- Colorectal cancer1 trial
- and 10 more
- Phase
- Phase 313 trials
- Phase 13 trials
- Phase 1/21 trial
- Phase 21 trial
- Phase 2/31 trial
- Phase 41 trial
- Status
- Completed9 trials
- Active, not recruiting8 trials
- Terminated5 trials
- Recruiting4 trials
- Lead sponsor
- Novartis Pharmaceuticals26 trials
Running trials
Active, not recruiting
Recruiting
Recruiting
Recruiting
Active, not recruiting
Active, not recruiting
ITAKOS - Italian Observation, Multicenter, Prospective Study of Ofatumumab in RRMS Patients
Recruiting
Active, not recruiting
A Study of Inclisiran to Prevent Cardiovascular Events in High-risk Primary Prevention Patients.
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Hidradenitis suppurativa1 recruiting
- Multiple sclerosis1 recruiting
- Prostate cancer1 recruiting
Closed trials
Completed
Impact of Mayzent on aSPMS Patients in a Long-term NIS in Italy
Completed
Terminated
Terminated
A Phase I/Ib Study of NIZ985 Alone and in Combination With Spartalizumab
Completed
Completed
Completed
Terminated
Completed
Terminated
A Phase Ib Study of LXH254-centric Combinations in NSCLC or Melanoma
Terminated
Completed
Completed
Nilotinib Treatment-free Remission Study in CML (Chronic Myeloid Leukemia) Patients
Completed
A Study of LGK974 in Patients With Malignancies Dependent on Wnt Ligands
Site data: ClinicalTrials.govUpdated 13 Nov 2026